- Home
- TLSI vs CXDO Comparison
TLSI vs CXDO Comparison
Compare TLSI & CXDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- CXDO
- Stock Information
- Founded
- TLSI 2010
- CXDO 1995
- Country
- TLSI United States
- CXDO United States
- Employees
- TLSI N/A
- CXDO 185
- Industry
- TLSI Medical Specialities
- CXDO Telecommunications Equipment
- Sector
- TLSI Health Care
- CXDO Telecommunications
- Exchange
- TLSI Nasdaq
- CXDO Nasdaq
- Market Cap
- TLSI 244.3M
- CXDO 196.8M
- IPO Year
- TLSI N/A
- CXDO 1998
- Fundamental
- Price
- TLSI $4.70
- CXDO $6.25
- Analyst Decision
- TLSI Strong Buy
- CXDO Strong Buy
- Analyst Count
- TLSI 4
- CXDO 4
- Target Price
- TLSI $11.13
- CXDO $8.75
- AVG Volume (30 Days)
- TLSI 131.5K
- CXDO 81.8K
- Earning Date
- TLSI 11-13-2025
- CXDO 11-04-2025
- Dividend Yield
- TLSI N/A
- CXDO N/A
- EPS Growth
- TLSI N/A
- CXDO 13.31
- EPS
- TLSI N/A
- CXDO 0.11
- Revenue
- TLSI $35,990,000.00
- CXDO $64,476,000.00
- Revenue This Year
- TLSI $56.71
- CXDO $13.46
- Revenue Next Year
- TLSI $52.25
- CXDO $11.27
- P/E Ratio
- TLSI N/A
- CXDO $56.98
- Revenue Growth
- TLSI 45.50
- CXDO 13.10
- 52 Week Low
- TLSI $3.42
- CXDO $3.75
- 52 Week High
- TLSI $5.88
- CXDO $7.34
- Technical
- Relative Strength Index (RSI)
- TLSI 45.51
- CXDO 51.94
- Support Level
- TLSI $4.87
- CXDO $6.18
- Resistance Level
- TLSI $5.18
- CXDO $6.52
- Average True Range (ATR)
- TLSI 0.23
- CXDO 0.20
- MACD
- TLSI -0.01
- CXDO 0.03
- Stochastic Oscillator
- TLSI 44.74
- CXDO 77.27
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.